The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor

被引:19
|
作者
Pergantou, H. [1 ]
Xafaki, P. [1 ]
Adamtziki, E. [1 ]
Koletsi, P. [1 ]
Komitopoulou, A. [1 ]
Platokouki, H. [1 ]
机构
[1] Aghia Sophia Childrens Hosp, Haemophilia Ctr, Haemostasis Unit, GR-11527 Athens, Greece
关键词
ALLOANTIBODIES; ANAPHYLAXIS; COMPLEMENT; PATIENT;
D O I
10.1111/j.1365-2516.2012.02799.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e66 / e67
页数:2
相关论文
共 50 条
  • [1] The challenging management of a child with type 3 von Willebrand disease (VWD) and antibodies to von Willebrand factor (VWF)
    Platokouki, H.
    Pergantou, H.
    Xafaki, P.
    Adamtziki, E.
    [J]. HAEMOPHILIA, 2012, 18 : 44 - 44
  • [2] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [3] Von Willebrand factor inhibitors developed in type 3 von Willebrand disease
    Megdiche, F.
    Kassar, O.
    Hdiji, S.
    Mbarek, L.
    Charfi, M.
    Elloumi, M.
    Kallel, C.
    [J]. HAEMOPHILIA, 2019, 25 : 87 - 87
  • [4] von Willebrand disease and von Willebrand factor
    Sadler, Brooke
    Castaman, Giancarlo
    O'Donnell, James S.
    [J]. HAEMOPHILIA, 2022, 28 : 11 - 17
  • [5] von Willebrand Factor and von Willebrand Disease
    王兆钺
    [J]. 血栓与止血学, 2005, (04) : 147 - 149
  • [6] VON WILLEBRAND FACTOR INHIBITORS IN TYPE 3 VON WILLEBRAND DISEASE: CHALLENGES IN DIAGNOSIS
    Megdiche, F.
    Kassar, O.
    Krichen, I.
    Kallel, F.
    Ghorbel, M.
    Elloumi, M.
    Kallel, C.
    [J]. HAEMOPHILIA, 2020, 26 : 135 - 135
  • [7] Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease
    Rydz, N.
    Grabell, J.
    Lillicrap, D.
    James, P.
    [J]. HAEMOPHILIA, 2012, 18 : 198 - 198
  • [8] Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease
    Rydz, N.
    Grabell, J.
    Lillicrap, D.
    James, P. D.
    [J]. HAEMOPHILIA, 2015, 21 (05) : 636 - 641
  • [9] Von Willebrand factor and von Willebrand disease - Preface
    Michiels, JJ
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) : VII - VII
  • [10] Treatment of a patient with type 3 von Willebrand disease and alloantibody against von Willebrand factor
    Halimeh, S.
    Faeser, B.
    Budde, U.
    Laws, H.
    Rott, H.
    [J]. HAEMOPHILIA, 2010, 16 : 149 - 149